Company profile: InGen BioSciences
1.1 - Company Overview
Company description
- Provider of mono and multiparametric in vitro diagnostic kits and products, focused on developing and marketing in vitro diagnostic tools.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to InGen BioSciences
BioLamina
HQ: Sweden
Website
- Description: Provider of cell culture matrices based on human recombinant laminins for primary cells and stem cell applications. Products include Biolaminin 521 LN and 521 MX for chemically defined, feeder-free self-renewal of human ES/iPS cells (LN: animal origin-free; MX: animal origin-free to the secondary level); 521 CTG for clinical studies and feeder-free culture of PSCs, MSCs, and progenitor cells; 111/121 LN as general attachment proteins; and 211 LN for tissue-specific cell growth and differentiation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioLamina company profile →
March Therapeutics
HQ: United States
Website
- Description: Provider of genome-based services leveraging proprietary molecular recording technologies and advanced computing to discover and optimize therapeutic enzymes. Offers ultra-high-throughput mapping of protein sequence to function, generating scalable sequence-based datasets to accelerate therapeutic development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full March Therapeutics company profile →
Synlogic
HQ: United States
Website
- Description: Provider of synthetic biotic medicines designed to perform metabolic functions to treat diseases.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synlogic company profile →
CustomArray
HQ: United States
Website
- Description: Provider of oligonucleotide pool libraries to many of the world’s premier academic and industrial organizations for applications including synthetic biology, gene synthesis, CRISPR, targeted sequencing, complex DNA libraries, shRNA libraries, and DNA data storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CustomArray company profile →
Locus Biosciences
HQ: United States
Website
- Description: Provider of CRISPR-engineered precision antibacterial therapies using bacteriophages. Portfolio includes LBP-EC01 for E. coli urinary tract infections; LBP-PA01 and LBP-SA01 targeting P. aeruginosa and S. aureus with Janssen; and LBP-KP01 for K. pneumoniae supported by CARB-X. Also offers robotic bacteriophage discovery and synthetic biology to engineer phage products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Locus Biosciences company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for InGen BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to InGen BioSciences
2.2 - Growth funds investing in similar companies to InGen BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for InGen BioSciences
4.2 - Public trading comparable groups for InGen BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →